Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

85.7K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
85.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mutation-specific neuropathologic signatures in MAPT-associated frontotemporal lobar degeneration.

Acta neuropathologica·2026
Same author

Genome wide association study meta-analysis of neuropathologic lesions of Alzheimer's disease and related dementias in a multi-site autopsy cohort.

PLoS genetics·2026
Same author

Combining post-mortem and neuroimaging measures of brain amyloidosis to accelerate genomic discovery.

Brain : a journal of neurology·2026
Same author

Riboregulation: a non-canonical tau function.

Molecular neurodegeneration·2026
Same author

Traumatic brain injury and late-life Alzheimer's disease neuropathology: Quantitative investigation in the Adult Changes in Thought study.

Journal of Alzheimer's disease : JAD·2026
Same author

Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease.

Acta neuropathologica·2026

相关实验视频

Updated: Jan 11, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K

三-snRNP活动调节病症表型.

Katherine R LeBlanc1,2, Randall J Eck1,3, Aleen D Saxton4

  • 1Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle 98104 WA, United States.

NAR molecular medicine
|November 19, 2025
PubMed
概括

dib-1基因的突变通过改善RNA拼接来保护阿尔茨海默病 (AD) 和其他类型的疾病. 这一发现表明,向结合体可以治疗神经退行性疾病.

更多相关视频

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1000

相关实验视频

Last Updated: Jan 11, 2026

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
09:22

In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein

Published on: January 2, 2015

18.9K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K
Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases
10:38

Author Spotlight: Understanding the Impact of Pathological Proteins on Axonal Transport in Neurodegenerative Diseases

Published on: December 22, 2023

1000

科学领域:

  • 神经科学是一个神经科学.
  • 分子生物学分子生物学
  • 遗传学 是一个遗传学.

背景情况:

  • 阿尔茨海默病 (AD) 和陶病是影响认知和记忆的神经退行性疾病.
  • 病原性陶在大脑中的积累是这些疾病的标志.
  • 在Caenorhabditis elegans的模型中,重新总结了人类病的关键方面,包括神经退行.

研究的目的:

  • 为了确定调节病理的遗传因素,使用前置遗传选在C. 优雅的模型.
  • 研究dib-1基因及其人类同类TXNL4A在病症中的作用.
  • 探索RNA剪接和病中的神经退行之间的联系.

主要方法:

  • 在C.C.中转发基因选. elegans用于识别影响tau病理的突变.
  • 描述dib-1突变对tau驱动的表型,神经退行和tau水平的影响.
  • RNA测序用于分析dib-1突变体中的基因表达和拼接模式.
  • 研究与dib-1突变相关的无意中介衰变途径.

主要成果:

  • 在dib-1中发生的单点突变显著改善了tau驱动的行为缺陷,预防了神经退行,并降低了tau蛋白水平.
  • dib-1编码TXNL4A,这是spliceosome的tri-snRNP复合体的一个组成部分.
  • RNA测序揭示了dib-1突变体中广泛存在的内部保留,这表明拼接中断.
  • 在prp-8中丧失功能,另一个tri-snRNP成分,也受到保护.
  • 在人类AD前皮层样本中发现TXNL4A水平下降.

结论:

  • 病态的积似乎会损害结合体功能.
  • 正如"dib-1"突变所示,调节结合体活性可以改善病症.
  • 该dib-1/TXNL4A通路代表了阿尔茨海默氏症和其他病的潜在治疗标.